Cargando…

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells

Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) are promising molecules for therapeutic or prophylactic interventions. Beyond neutralization, bNAbs exert Fc-dependent functions including antibody-dependent cellular cytotoxicity and activation of the complement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dufloo, Jérémy, Planchais, Cyril, Frémont, Stéphane, Lorin, Valérie, Guivel-Benhassine, Florence, Stefic, Karl, Casartelli, Nicoletta, Echard, Arnaud, Roingeard, Philippe, Mouquet, Hugo, Schwartz, Olivier, Bruel, Timothée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810770/ https://www.ncbi.nlm.nih.gov/pubmed/35110562 http://dx.doi.org/10.1038/s41467-022-28307-7

Ejemplares similares

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Bruel, Timothée, et al.
Publicado: (2016)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2020)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2021)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
por: Prigent, Julie, et al.
Publicado: (2018)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018)

HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells
por: Planchais, Cyril, et al.
Publicado: (2019)

The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
por: Casartelli, Nicoletta, et al.
Publicado: (2010)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2022)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2023)

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
por: Bruel, Timothée, et al.
Publicado: (2022)

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
por: Planchais, Cyril, et al.
Publicado: (2022)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer
por: Malbec, Marine, et al.
Publicado: (2013)

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
por: Rajah, Maaran Michael, et al.
Publicado: (2021)

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
por: Saunders, Nell, et al.
Publicado: (2022)

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
por: Planas, Delphine, et al.
Publicado: (2022)

Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
por: Monel, Blandine, et al.
Publicado: (2017)

Tetherin Restricts Productive HIV-1 Cell-to-Cell Transmission
por: Casartelli, Nicoletta, et al.
Publicado: (2010)

Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity
por: Goldberg, Benjamin S., et al.
Publicado: (2021)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2021)

Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers
por: Hehle, Verena, et al.
Publicado: (2020)

Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
por: Jones, Thane, et al.
Publicado: (2023)

Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier
por: Lorin, Valérie, et al.
Publicado: (2020)

Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission
por: Luo, Xiaoyu, et al.
Publicado: (2021)

Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
por: Malbec, Marine, et al.
Publicado: (2013)

Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2023)

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
por: Torres, Jonathan L., et al.
Publicado: (2022)

Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway
por: Joubert, Pierre-Emmanuel, et al.
Publicado: (2015)

Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques
por: Kelkar, Natasha S., et al.
Publicado: (2023)

IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread
por: Compton, Alex A., et al.
Publicado: (2014)

Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
por: Molinos-Albert, Luis M., et al.
Publicado: (2022)

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
por: Hubert, Mathieu, et al.
Publicado: (2023)

Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies
por: Pham, Tram N. Q., et al.
Publicado: (2016)

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
por: Smith, Nikaïa, et al.
Publicado: (2021)

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
por: Bruel, Timothée, et al.
Publicado: (2022)

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
por: Grzelak, Ludivine, et al.
Publicado: (2020)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections
por: Rascle, Philippe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tg1fmodpr8m3sp83ph2fjst63e